World

UAE starts Covid-19 vaccinations in capital

About 45 Abu Dhabi hospitals and clinics equipped with Sinopharm inoculation

Updated 5 years ago · Published on 14 Dec 2020 8:30PM

UAE starts Covid-19 vaccinations in capital
The Sinopharm vaccine is administered in two doses, 21 days apart, and its distribution has begun in the United Arab Emirates. – Pixabay pic, December 14, 2020

ABU DHABI – The United Arab Emirates has launched Covid-19 vaccinations in its capital Abu Dhabi, health officials said today, days after it approved the jab by Chinese drugs giant Sinopharm. 

The wealthy Gulf nation is one of the first countries to start widespread inoculation, after Britain became the first to roll out a campaign using a vaccine by US pharmaceutical giant Pfizer and its German partner BioNTech. 

Gulf countries UAE and Bahrain, where third-phase trials of the Sinopharm vaccine were carried out, have both officially registered it for public use after it was previously approved for emergency use for front-line health workers.  

Residents in the capital can book an appointment through the Abu Dhabi Health Services (Seha) hotline.

“Residents can book an appointment for the vaccine now, free of charge,” a Seha operator told AFP, with local reports saying at least 45 hospitals and clinics were equipped with the vaccine.

Sinopharm – which uses an inactive form of the novel coronavirus – is administered in two doses, 21 days apart, according to Seha.

The UAE has so far recorded more than 184,000 novel coronavirus cases, including 617 deaths. 

China has four vaccines, including Sinopharm, in the final stages of development and is well advanced with mass human testing in a number of countries, including Brazil, the UAE and Turkey.

But unlike vaccines being developed by Moderna, AstraZeneca and Johnson & Johnson, little information has been published about the safety or efficacy of Chinese vaccines.

In Peru, clinical trials of a Sinopharm vaccine were suspended after neurological problems were detected in a test volunteer.

Chinese vaccine front runners Sinovac and Sinopharm had pre-orders for fewer than 500 million doses by mid-November, according to data from London consultancy Airfinity – mostly from countries that participated in trials.

Britain’s AstraZeneca, meanwhile, has pre-orders for 2.4 billion doses, and Pfizer for about half a billion orders.

Two vaccines have undergone third-phase trials in the UAE – the Sinopharm project and Russia’s Sputnik-V, named after the Soviet-era satellite.

Dubai ruler Sheikh Mohammed Rashid Al-Maktoum said in November that he had received an experimental coronavirus vaccine, joining other top UAE officials in taking part in the trials. – AFP, December 14, 2020

Related News

Malaysia / 2y

Current health ailments not related to AstraZeneca vaccine, says Noor Hisham

Malaysia / 2y

Govt aware of AstraZeneca vaccine side effects when it was deployed, says Noor Hisham

World / 2y

AstraZeneca Covid-19 vaccine to be withdrawn globally

World / 2y

AstraZeneca admits Covishield can cause blood clots, low platelet count

Malaysia / 2y

8.5 million doses of Covid-19 vaccine worth RM505 mil expired since June 1: PAC

World / 3y

German courts confront suits against vaccine makers BioNTech, AstraZeneca

Spotlight

Malaysia

Nhaveen murder trial: Accused admits taunting victim but denies fatal assault

Malaysia

MCMC probes alleged AI sexual abuse targeting Kedah pupils, teachers

Malaysia

Anwar checks final preparations for Budget 2027

Malaysia

Sarawak election could be called within weeks of Budget 2027

Malaysia

Anwar contacts Prabowo over ‘alarming’ transboundary haze

Malaysia

King calls for schools in haze-hit areas to close

Malaysia

Parents worry over children’s exposure as haze worsens

By Alfian Z.M. Tahir

You may be interested

World

Explosions rock Riyadh airport as Yemen’s Houthis claim missile attack

World

AI agents used in cyberattacks targeting South Korean banks, CrowdStrike says

World

US to livestream Nidal Hasan’s firing squad execution on December 3

World

Indonesia forest fire hotspots plunge 67%, but haze and dry weather risks persist

World

59,275 hotspots turn South Sumatra into haze hotspot as respiratory cases surge